Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort

Denver Emergency Department HIV Research Consortium

doi:10.1097/QAI.0000000000000518

Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort

Denver Emergency Department HIV Research Consortium

School of Medicine

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6% newly diagnosed infections were identified. Of all visits, 9% were very low risk (HIV prevalence 0.20%), 27% low risk (HIV prevalence 0.17%), 41% moderate risk (HIV prevalence 0.39%), 17% high risk (HIV prevalence 1.19%), and 6% very high risk (HIV prevalence 3.57%). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.

Original language	English (US)
Pages (from-to)	599-603
Number of pages	5
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	68
Issue number	5
DOIs	https://doi.org/10.1097/QAI.0000000000000518
State	Published - Apr 15 2015

Keywords

Denver HIV Risk Score
HIV infection
epidemiology
risk
screening
targeted
validation

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)

Access to Document

10.1097/QAI.0000000000000518

Cite this

@article{ab1799a373f74f7bbca6511ef3248a56,

title = "Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort",

abstract = "Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6% newly diagnosed infections were identified. Of all visits, 9% were very low risk (HIV prevalence 0.20%), 27% low risk (HIV prevalence 0.17%), 41% moderate risk (HIV prevalence 0.39%), 17% high risk (HIV prevalence 1.19%), and 6% very high risk (HIV prevalence 3.57%). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.",

keywords = "Denver HIV Risk Score, HIV infection, epidemiology, risk, screening, targeted, validation",

author = "{Denver Emergency Department HIV Research Consortium} and Haukoos, {Jason S.} and Emily Hopkins and Bucossi, {Meggan M.} and Lyons, {Michael S.} and Rothman, {Richard E.} and White, {Douglas A.E.} and Al-Tayyib, {Alia A.} and Lucy Bradley-Springer and Campbell, {Jonathan D.} and Sabel, {Allison L.} and Thrun, {Mark W.}",

year = "2015",

month = apr,

day = "15",

doi = "10.1097/QAI.0000000000000518",

language = "English (US)",

volume = "68",

pages = "599--603",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Brief report

T2 - Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort

AU - Denver Emergency Department HIV Research Consortium

AU - Haukoos, Jason S.

AU - Hopkins, Emily

AU - Bucossi, Meggan M.

AU - Lyons, Michael S.

AU - Rothman, Richard E.

AU - White, Douglas A.E.

AU - Al-Tayyib, Alia A.

AU - Bradley-Springer, Lucy

AU - Campbell, Jonathan D.

AU - Sabel, Allison L.

AU - Thrun, Mark W.

PY - 2015/4/15

Y1 - 2015/4/15

N2 - Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6% newly diagnosed infections were identified. Of all visits, 9% were very low risk (HIV prevalence 0.20%), 27% low risk (HIV prevalence 0.17%), 41% moderate risk (HIV prevalence 0.39%), 17% high risk (HIV prevalence 1.19%), and 6% very high risk (HIV prevalence 3.57%). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.

AB - Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6% newly diagnosed infections were identified. Of all visits, 9% were very low risk (HIV prevalence 0.20%), 27% low risk (HIV prevalence 0.17%), 41% moderate risk (HIV prevalence 0.39%), 17% high risk (HIV prevalence 1.19%), and 6% very high risk (HIV prevalence 3.57%). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.

KW - Denver HIV Risk Score

KW - HIV infection

KW - epidemiology

KW - risk

KW - screening

KW - targeted

KW - validation

UR - http://www.scopus.com/inward/record.url?scp=84925273749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925273749&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000000518

DO - 10.1097/QAI.0000000000000518

M3 - Article

C2 - 25585300

AN - SCOPUS:84925273749

SN - 1525-4135

VL - 68

SP - 599

EP - 603

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 5

ER -

Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this